Russell Alan J - Nov 15, 2021 Form 4 Insider Report for Edgewise Therapeutics, Inc. (EWTX)

Role: Chief Scientific Officer, Director
Signature: /s/ John R. Moore, Attorney-in-Fact for Russell Alan J
Stock symbol: EWTX
Transactions as of: Nov 15, 2021
Transactions value $: -$9,155
Form type: 4
Date filed: 11/17/2021, 05:05 PM
Previous filing: Nov 12, 2021
Next filing: Dec 1, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EWTX	Common Stock	Sale	-$8.41K	-441	-92.07%	$19.07	38	Nov 15, 2021	Direct	F1, F2
transaction	EWTX	Common Stock	Sale	-$745	-38	-100%	$19.61	0	Nov 15, 2021	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on June 17, 2021.
F2	The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $18.56 to $19.52, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Content

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on June 17, 2021.

The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $18.56 to $19.52, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.